Clomipramine hydrochloride
Company: Mylan Laboratories
Approval Status: Approved April 1998
Treatment for: depression
Areas: Endocrinology; Psychiatry/Psychology
General Information
Other Useful Resources
Clomipramine hydrochloride capsules, the generic equivalent of Novartis' Anafranil, have been approved. The drug will be manufactured in 25 mg, 50 mg, and 75 mg strengths.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
